Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: EXPAREL in hip fracture
NCT03955458Phase 4Withdrawn
- Sponsor
- Pacira BioSciences
- Start
- Aug 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine extended release liposome injection in postoperative pain, sponsored by Pacira BioSciences. Planned start Aug 2019; status: withdrawn.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03955458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03955458.